ICUI ICU Medical Dashboard

ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

Company profile

Ticker

ICUI

Exchange

NASDAQ

Website

www.icumed.com/

CEO

Vivek Jain

Incorporated

Delaware

Location

California

Fiscal year end

Dec 31

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Surgical & Medical Instruments & Apparatus

Boston Scientific • Baxter International • Becton, Dickinson And • 3M • Stryker • Teleflex • Resmed • Hill-Rom • Integra Lifesciences • Nuvasive ...

SEC CIK

0000883984

Corporate docs

Articles of Incorporation & Bylaws

IRS number

330022692

ICUI stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

10 Health Care Stocks With Unusual Options Alerts In Today's Session

22 Mar 21

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Unusual trading activity could push option prices to exaggerated or underestimated levels.

Raymond James Maintains Outperform on ICU Medical, Raises Price Target to $245

26 Feb 21

Raymond James analyst Jayson Bedford maintains ICU Medical (NASDAQ:ICUI) with a Outperform and raises the price target from $235 to $245.

ICU Medical Q4 Adj. EPS $1.77 Beats $1.51 Estimate, Sales $320.50M Beat $295.33M Estimate

25 Feb 21

ICU Medical (NASDAQ:ICUI) reported quarterly earnings of $1.77 per share which beat the analyst consensus estimate of $1.51 by 17.22 percent. This is a 8.76 percent decrease over earnings of $1.94 per share from the same

The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants

25 Feb 21

Earnings Scheduled For February 25, 2021

25 Feb 21

Press releases

Pro users get this 30m faster

ICU Medical, Inc. Announces Fourth Quarter 2020 Results and Provides Fiscal Year 2021 Guidance

25 Feb 21

SAN CLEMENTE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care

ICU Medical, Inc. to Host Earnings Call

25 Feb 21

NEW YORK, NY / ACCESSWIRE / February 25, 2021 / ICU Medical, Inc. (NASDAQ:ICUI) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 25, 2021 at 4:30 PM Eastern

ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2020 Earnings Conference Call

4 Feb 21

SAN CLEMENTE, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (NASDAQ:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care

ICU Medical's Plum 360™ Infusion System Receives First-Ever Best in KLAS Honor as Top-Performing Smart Pump EMR-Integrated

2 Feb 21

Calendar

26 Feb 21

13 Apr 21

31 Dec 21

Financial summary

Financial statements Chart ICUI financial data

Quarter (USD)	Dec 20	Sep 20	Jun 20	Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from ICU Medical earnings reports.

Recent insider trades

ICUI insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
12 Apr 21	Lopez George A	Common Stock	Sell	Dispose S	Yes	Yes	206.7763	384	79.4K	936,843
12 Apr 21	Lopez George A	Common Stock	Sell	Dispose S	Yes	Yes	206.1047	4,149	855.13K	937,227
12 Apr 21	Lopez George A	Common Stock	Sell	Dispose S	Yes	Yes	205.2256	167	34.27K	941,376
9 Apr 21	Lopez George A	Common Stock	Sell	Dispose S	Yes	Yes	204.7	400	81.88K	941,543
9 Apr 21	Lopez George A	Common Stock	Sell	Dispose S	Yes	Yes	203.8431	5,350	1.09M	941,943
9 Apr 21	Lopez George A	Common Stock	Sell	Dispose S	Yes	Yes	203.1075	4,650	944.45K	947,293
8 Apr 21	Lopez George A	Common Stock	Sell	Dispose S	Yes	Yes	204.9901	1,118	229.18K	951,943
8 Apr 21	Lopez George A	Common Stock	Sell	Dispose S	Yes	Yes	203.9982	2,868	585.07K	953,061
8 Apr 21	Lopez George A	Common Stock	Sell	Dispose S	Yes	Yes	203.216	5,914	1.2M	955,929
5 Apr 21	Lopez George A	Common Stock	Sell	Dispose S	Yes	Yes	208.5	25	5.21K	961,843

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2020

ICUI institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

92.1% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	272	269	+1.1%
Opened positions	34	36	-5.6%
Closed positions	31	46	-32.6%
Increased positions	88	85	+3.5%
Reduced positions	102	101	+1.0%

13F shares	Current	Prev Q	Change
Total value	7.72B	4.51B	+71.1%
Total shares	19.47M	19.11M	+1.9%
Total puts	1.4K	15.1K	-90.7%
Total calls	75.9K	70.2K	+8.1%
Total put/call ratio	0.0	0.2	-91.4%

Largest owners	Shares	Value	Change
TROW T. Rowe Price	2.64M	$566.33M	-0.6%
JHG Janus Henderson	2.62M	$562.76M	-11.0%
Vanguard	1.81M	$387.23M	+2.1%
BLK Blackrock	1.66M	$356.25M	-0.0%
Nuance Investments	901.48K	$193.36M	+23.5%
JPM JPMorgan Chase & Co.	771.75K	$165.53M	+13.2%
Findlay Park Partners	528.83K	$113.43M	+17.5%
STT State Street	495.96K	$106.38M	+1.9%
Nitorum Capital	417.24K	$89.49M	+0.4%
Victory Capital Management	405.2K	$86.91M	+1.9%

Largest transactions	Shares	Bought/sold	Change
JHG Janus Henderson	2.62M	-323.57K	-11.0%
Norges Bank	184.89K	+184.89K	NEW
Nuance Investments	901.48K	+171.81K	+23.5%
IVZ Invesco	211.76K	+102.86K	+94.5%
JPM JPMorgan Chase & Co.	771.75K	+89.84K	+13.2%
Redmile	241.45K	+83.4K	+52.8%
Findlay Park Partners	528.83K	+78.83K	+17.5%
Citadel Advisors	93.25K	+75.51K	+425.6%
Schroder Investment Management	156.51K	+71.25K	+83.6%
Jacobs Levy Equity Management	62.33K	-69.36K	-52.7%

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Merit Medical Systems • Edwards Lifesciences • Acelrx Pharmaceuticals

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: apubliclyannouncedprogram, Averageprice, Biden, border, career, category, cessation, CFO, childcare, cleaning, CPRA, creativity, customary, daycare, dedesignation, distancing, earthquake, economy, entertainment, exhilarating, expiry, fault, feasible, fight, flourish, foundation, freedom, frequency, handler, hygiene, iLearning, inspiring, irrevocably, lawfully, learning, lengthen, manipulation, matrix, meant, merge, migration, mindset, mission, Montreal, movement, notably, paidper, pandemic, paramount, Parliament, precautionary, predetermined, preemptively, prioritization, prioritize, progressed, questionnaire, rapidly, reinterpreted, repay, rescinded, resolved, resumption, rewarding, school, Sharespurchased, Shield, shift, spread, stable, stemming, strive, Supreme, susceptible, talent, talented, technician, temperature, tuition, unknown, upholding, urgent, visibility, visitor, wider, won, Wuhan

Removed: acceleration, account, allege, alleged, allegedly, amend, analyzed, antitrust, artificially, assemble, Attorney, attributable, bargain, bore, Bulletin, close, comprised, compute, considerably, contemplated, core, decreasing, defendant, delivered, disadvantage, distributed, downturn, drop, earlier, earn, earnout, Eastern, eighteen, eleven, embodying, Enabling, equally, estate, exceeded, Excelsior, excise, financed, floor, footnote, footprint, forgo, Function, Germany, grand, headcount, hired, historic, Impracticable, Jose, jury, lack, leasing, Ludenscheid, macroeconomic, mandatory, marketability, mentioned, MLA, nonrecurring, NovaCath, October, operation, organizing, owner, peripheral, procurement, provisional, purported, putative, qualitative, quantify, real, reassessed, recessionary, redesign, reevaluated, rendered, repayment, represented, retained, SAB, saline, Sapphire, scenario, seller, Simplifying, slightly, stand, submission, subpoena, SuperCath, sustain, taxable, territorial, toll, treated, treble, unlawful, unrelated, variance, verified, York

From filing 10-K 2020 FY